Carregant...
Advancing Novel PrEP Products – Alternatives to Non-Inferiority
With the scale-up of HIV pre-exposure prophylaxis (PrEP) with tenofovir (TDF) with or without emtricitabine (FTC), we have entered an era of highly effective HIV prevention with a growing pipeline of potential products to be studied. These studies are likely to be randomized trials with an oral TDF/...
Guardat en:
| Publicat a: | Stat Commun Infect Dis |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6731035/ https://ncbi.nlm.nih.gov/pubmed/31497242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/scid-2019-0011 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|